no antibiotic prophylaxis
PreclinicalSmall molecule
no antibiotic prophylaxis is one of 6 small molecule programs targeting Achalasia. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
12 competitors in Achalasia
#DrugCompanyPhaseTrials
1Avycaz
PPhiladelphia Eye Associates
Approved
Myrbetriq
AstellasPhase 1
Botox
RRevance Therapeutics, Inc.
Preclinical
Olinciguat
CCyclerion Therapeutics
Phase 2
Second Generation Cephalosporin
SShanghai Zhongshan Hospital
Preclinical
no antibiotic prophylaxis
SShanghai Zhongshan Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for no antibiotic prophylaxis. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- SShanghai Zhongshan Hospital